Open AccessLongitudinal findings from a randomized clinical trial of naltrexone for young adult heavy drinkers.
Author(s) -
Kelly S. DeMartini,
Ralitza Gueorguieva,
Robert F. Leeman,
William R. Corbin,
Lisa M. Fucito,
Henry R. Kranzler,
Stephanie S. O’Malley
Publication year - 2016
Publication title -
journal of consulting and clinical psychology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.582
H-Index - 240
eISSN - 1939-2117
pISSN - 0022-006X
DOI - 10.1037/ccp0000053
Subject(s) - naltrexone , placebo , discontinuation , randomized controlled trial , young adult , psycinfo , medicine , psychology , longitudinal study , clinical trial , psychological intervention , psychiatry , medline , opioid , alternative medicine , receptor , pathology , political science , law
Behavioral interventions for young adults show limited effects 1-year posttreatment. Few studies have examined the longitudinal outcomes of pharmacotherapy trials to reduce heavy drinking. This study examined the posttreatment, longitudinal effects of the first placebo-controlled trial of naltrexone in young adult heavy drinkers.